Quantcast

Latest Hospira Stories

2014-07-08 23:10:01

GIA announces the release of a comprehensive global report on Pharmaceutical Contract Manufacturing markets. Global market for Pharmaceutical Contract Manufacturing is forecast to reach US$23.4 million by 2020, spurred by pricing pressures and shrinking margins aggravated by patent expiries, regulatory and competitive pressures, and emergence of generics to replace blockbuster drugs nearing patent expiries. San Jose, California (PRWEB) July 08, 2014 Global pharmaceutical contract...

2014-07-08 23:08:23

ReportsnReports.com adds “PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market” to its store. Lucrative Biosimilars Space to Erode Biologics Market from 2019. Dallas, Texas (PRWEB) July 08, 2014 The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking the overall biologics market value from $162 billion in...

2014-07-04 16:21:01

-- Purchase enhances cost-competitiveness, paves way for future development -- LAKE FOREST, Ill., July 4, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced it has completed the acquisition of an active pharmaceutical ingredient (API) manufacturing facility and an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals Ltd. (BSE: 524372, NSE:...

2014-07-01 12:28:22

LAKE FOREST, Ill., July 1, 2014 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, will host a conference call to discuss its second-quarter 2014 results on Wednesday, July 30, 2014 at 8 a.m. Central time. The company will release its second-quarter results earlier that morning, before the U.S. stock market open and the conference call. A live webcast of the conference call and related material will be available...

2014-06-26 16:24:35

DUBLIN, June 26, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/cqw9hq/infusion_pumps) has announced the addition of the "2014 Report on the International Infusion Pumps Market - Forecasts to 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Infusions are carried out to deliver therapeutic drugs and fluids into body via various routes such as intravenous, arterial, peritoneal, enteral, intrathecal and subcutaneous....

2014-06-25 08:32:36

$1.5 million in proceeds to fund 2014 commencement of HPPI's clinical development program for repurposing the approved anti-fungal drug itraconazole for the treatment of cancer, initially for the treatment of Basal Cell Carcinoma Nevus Syndrome TAMPA, Fla. and SAN DIEGO, June 25, 2014 /PRNewswire/ -- HedgePath Pharmaceuticals, Inc. (OTCQB:HPPI) a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with...

2014-06-23 12:29:32

DUBLIN, June 23, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/s4hmm7/global_pain) has announced the addition of the "Global Pain Management Devices Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 SCS therapy is becoming increasingly popular for the treatment of chronic, refractory, and neuropathic pain. Pain management therapy using SCS devices involves MI implantation of electrodes into the epidural...

2014-06-23 12:28:46

LONDON, June 23, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Testicular Cancer Drugs Market 2014-2018http://www.reportbuyer.com/pharma_healthcare/therapeutic/global_testicular_cancer_drugs_market_2014_2018.html TechNavio's analysts forecast the Global Testicular Cancer Drugs market to grow at a CAGR of 4.02 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing incidence of testicular...

2014-06-19 23:09:27

On June 18, the FDA published a voluntary recall for one lot of Marcaine (Bupivacaine HCI Injection, USP), 0.5 percent, 30 ML, Single-Dose, Preservative-Free, by Hospira, due to visible particulates. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 19, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on...

2014-06-10 23:16:23

On May 2, the FDA announced that Abbott Acclaim and Hospira Acclaim Encore Infusion Pumps, by Hospira, are recalled (Class I) due to broken door assemblies. In light of this news, AttorneyOne, a recognized authority on law, updated the website providing detailed information to consumers. San Diego, CA (PRWEB) June 10, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on safety alerts for Infusion Pumps. The FDA...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related